NCT04544527 The Risk Factors of Cardiovascular Disease in Elderly Diabetic Patients: A Prospective Cohort Study
| NCT ID | NCT04544527 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai Zhongshan Hospital |
| Condition | Diabetes Mellitus |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2020-09-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2020-09-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In the previous cohort studies focused on diabetes in China, there were few studies on elderly patients with diabetes. The aim of this prospective cohort study was to investigate the prevalence, management and nutritional status of elderly diabetic patients aged ≥65 years in Shanghai and Suzhou communities, and record the occurrence of endpoint events.
Eligibility Criteria
Inclusion Criteria: * Men or women aged 65-100 years old; * Patients who had been diagnosed with diabetes mellitus. Exclusion Criteria: * Patients with psychiatric disorders or impaired cognitive function; * Patients who cannot or reject to sign the consent form.
Contact & Investigator
Xiaoying Li, MD
PRINCIPAL INVESTIGATOR
Fudan University
Frequently Asked Questions
Who can join the NCT04544527 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 100 Years, studying Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04544527 currently recruiting?
Yes, NCT04544527 is actively recruiting participants. Contact the research team at li.xiaomu@zs-hospital.sh.cn for enrollment information.
Where is the NCT04544527 trial being conducted?
This trial is being conducted at Suzhou, China.
Who is sponsoring the NCT04544527 clinical trial?
NCT04544527 is sponsored by Shanghai Zhongshan Hospital. The principal investigator is Xiaoying Li, MD at Fudan University. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.